Sort   by:  
 Page size 
UnknownDoes coexisting accommodative dysfunction impact clinical convergence measures, symptoms and treatment success for symptomatic convergence insufficiency in children?
Not available
S-EPMC10544663 | biostudies-literature
UnknownEfficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients: A Randomized Clinical Trial.
Not available
S-EPMC8669605 | biostudies-literature
UnknownSix-Month Outcomes in the Long-Term Outcomes After the Multisystem Inflammatory Syndrome in Children Study.
Not available
S-EPMC11877180 | biostudies-literature
UnknownPooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC3074275 | biostudies-literature
UnknownEffectiveness of vergence/accommodative therapy for accommodative dysfunction in children with convergence insufficiency.
Not available
S-EPMC10545079 | biostudies-literature
UnknownGermline mutations in RAD51D confer susceptibility to ovarian cancer.
Not available
S-EPMC4845885 | biostudies-literature
UnknownVergence/accommodative therapy for symptomatic convergence insufficiency in children: Time course of improvements in convergence function.
Not available
S-EPMC9798873 | biostudies-literature
UnknownGenetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC3107565 | biostudies-literature
UnknownAssociation of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers.
Not available
S-EPMC3077716 | biostudies-literature
UnknownMutation and association analysis of GEN1 in breast cancer susceptibility.
Not available
S-EPMC3632835 | biostudies-literature
Sort   by:  
 Page size